The Cabinet has given its ex-post facto approval for the Memorandum of Understanding (MoU) between India and Iran on cooperation in the field of Health and Medicine.

Survivors of drug-resistant tuberculosis, health organisations and the TB community have appealed to Prime Minister Narendra Modi to allow issuance of compulsory licence for two of the essential dr

BENGALURU: Even as Tuberculosis (TB) activists are protesting for access to life-saving drugs Bedaquiline and Delaminid, in the national capital, in the backdrop of the End-TB Summit in Delhi to be

A group of doctors have written a letter to PM Modi demanding that the Centre exercise its right of ‘Compulsory Licensing’ (CL) for Bedaquiline and Delaminid, which treat drug-resistant forms of th

Invites proposals from the pharma industry to produce affordable medicines

NEW DELHI: Doctors at AIIMS have introduced a new technology for treating cancers affecting the abdominal lining, for example colon cancer or colorectal cancer.

In their search for new drugs against tuberculosis which is increasingly becoming resistant to presently available drugs, researchers are exploring all options.

Malawi has launched a new generation of typhoid vaccines making it the first country in Africa using the vaccines to fight typhoid infections in children.

The existing treatment regime against tuberculosis is not adequate, and novel therapeutic interventions are required to target Mycobacterium tuberculosis (Mtb) pathogenesis. We report Pranlukast (PRK) as a novel allosteric inhibitor of Mtb's arginine biosynthetic enzyme, Ornithine acetyltransferase (MtArgJ). PRK treatment remarkably abates the survival of free as well as macrophage‐internalized Mtb, and shows enhanced efficacy in combination with standard‐of‐care drugs.

Scientists have discovered crucial new processes that allow malaria parasites to escape red blood cells and infect other cells, offering potential new treatment targets.